奶粉巨头，突然暴跌，啥情况？

Core Viewpoint - The stock price of China Feihe (6186.HK) has significantly dropped due to the expected decline in performance for the first half of 2025, with projected revenues of approximately 9.1 billion to 9.3 billion yuan, down from about 10.1 billion yuan in the same period of 2024 [1][2][6]. Financial Performance - China Feihe anticipates revenues of approximately 91 billion to 93 billion yuan for the first half of 2025, representing a decrease from 101 billion yuan in the same period of 2024 [2][6]. - The company expects a net profit of around 1 billion to 1.2 billion yuan, down from approximately 1.9 billion yuan in 2024 [6]. - In 2024, China Feihe reported total revenue of 20.749 billion yuan and a net profit of 3.570 billion yuan [7]. Market Context - The infant formula industry in China has faced challenges due to declining birth rates, with a 5% and 10% decrease in market size in 2022 and 2023, respectively [7]. - The market is expected to stabilize in 2025, driven by a rebound in birth rates and government incentives for childbirth [7]. Strategic Initiatives - China Feihe plans to utilize at least 1 billion yuan for share buybacks, reflecting confidence in its long-term business prospects [9][10]. - The company will distribute dividends of no less than 2 billion yuan in 2025, despite short-term financial challenges [10][11]. - The company has increased its focus on high-end products and aims to enhance its market position through differentiated offerings [7][10]. Investor Relations - China Feihe has a strong commitment to returning value to investors, with a dividend payout of 0.3264 yuan per share in 2024, totaling 2.96 billion yuan, and a dividend rate of approximately 76% [11]. - The company is expected to maintain a stable sales expense ratio while increasing marketing efforts for its functional nutrition business [11].